US2022204963A1PendingUtilityA1
Oligosaccharides comprising an aminooxy group and conjugates thereof
Est. expiryJan 18, 2027(~0.5 yrs left)· nominal 20-yr term from priority
C12Y 302/01076C12Y 302/01022C12Y 302/0102C12Y 301/04012C12N 9/96C12N 9/2408C12N 9/16C07H 15/04A61P 43/00A61P 21/00A61P 3/00A61K 47/549A61K 38/47A61K 31/738
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods for the synthesis of oligosaccharides comprising an aminooxy group. The invention further provides oligosaccharides comprising an aminooxy group, methods for coupling oligosaccharides comprising an aminooxy group to glycoproteins, and oligosaccharide-protein conjugates. Also provided are methods of treating a lysosomal storage disorder in a mammal by administration of an oligosaccharide-protein conjugate.
Claims
exact text as granted — not AI-modified1 - 55 . (canceled)
56 . A method of treating fucosidosis in a patient, comprising administering to the patient (a) an effective amount of an oligosaccharide-acid α-L-fucosidase conjugate, comprising (1) acid α-L-fucosidase, (2) an oligosaccharide, and (3) an oxime group connecting the acid α-L-fucosidase and the oligosaccharide, and (b) an effective amount of an antipyretic, antihistamine, and/or immunosuppressant.
57 . A method of inducing immune tolerance towards an oligosaccharide-protein conjugate in a patient having mucopolysaccharidosis I, comprising administering to the patient an effective amount of cyclosporine A and azathioprine, wherein the oligosaccharide-protein conjugate comprises: (1) α-L-iduronidase, (2) an oligosaccharide, and (3) an oxime group connecting the α-L-iduronidase and the oligosaccharide.Join the waitlist — get patent alerts
Track US2022204963A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.